Clinical Trial Update: Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease

View source ↗

Summary

A clinical trial examining lymphocyte profiles and activation in patients with graft-versus-host disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Graft Versus Host Disease, Hematopoietic/Lymphoid Cancer | Status: WITHDRAWN